Daewoong Pharma (069620) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.057x

Based on the latest financial reports, Daewoong Pharma (069620) has a cash flow conversion efficiency ratio of 0.057x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩57.53 Billion ≈ $38.99 Million USD) by net assets (₩1.00 Trillion ≈ $680.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Daewoong Pharma to measure how many days the company can operate on defensive assets alone.

Daewoong Pharma - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Daewoong Pharma's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Daewoong Pharma Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Daewoong Pharma ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
LightPath Technologies Inc NASDAQ:LPTH	-0.060x
Guilin Seamild Foods Co Ltd SHE:002956	0.078x
National Presto Industries Inc NYSE:NPK	0.035x
China Reinsurance (Group) Corporation F:C53	0.064x
Shanghai Anoky Group SHE:300067	-0.006x
LegalZoom.com Inc NASDAQ:LZ	0.322x
Winall Hi tech Seed SHE:300087	0.016x
Voltalia SA PA:VLTSA	0.078x

Annual Cash Flow Conversion Efficiency for Daewoong Pharma (2007–2024)

The table below shows the annual cash flow conversion efficiency of Daewoong Pharma from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see 069620 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩926.98 Billion ≈ $628.20 Million	₩51.49 Billion ≈ $34.90 Million	0.056x	-66.35%
2023-12-31	₩802.97 Billion ≈ $544.16 Million	₩132.57 Billion ≈ $89.84 Million	0.165x	+3.52%
2022-12-31	₩741.22 Billion ≈ $502.32 Million	₩118.21 Billion ≈ $80.11 Million	0.159x	+180.10%
2021-12-31	₩702.41 Billion ≈ $476.01 Million	₩39.99 Billion ≈ $27.10 Million	0.057x	-60.80%
2020-12-31	₩695.25 Billion ≈ $471.16 Million	₩100.98 Billion ≈ $68.43 Million	0.145x	+60.35%
2019-12-31	₩635.92 Billion ≈ $430.95 Million	₩57.60 Billion ≈ $39.03 Million	0.091x	+15.90%
2018-12-31	₩607.81 Billion ≈ $411.90 Million	₩47.50 Billion ≈ $32.19 Million	0.078x	-52.52%
2017-12-31	₩631.54 Billion ≈ $427.98 Million	₩103.94 Billion ≈ $70.44 Million	0.165x	+547.03%
2016-12-31	₩604.55 Billion ≈ $409.70 Million	₩15.38 Billion ≈ $10.42 Million	0.025x	-58.87%
2015-12-31	₩580.24 Billion ≈ $393.22 Million	₩35.89 Billion ≈ $24.32 Million	0.062x	+8.59%
2014-12-31	₩455.51 Billion ≈ $308.69 Million	₩25.95 Billion ≈ $17.58 Million	0.057x	-53.94%
2013-12-31	₩437.96 Billion ≈ $296.80 Million	₩54.16 Billion ≈ $36.70 Million	0.124x	+6.17%
2012-12-31	₩386.59 Billion ≈ $261.98 Million	₩45.02 Billion ≈ $30.51 Million	0.116x	-46.45%
2011-12-31	₩362.42 Billion ≈ $245.60 Million	₩78.82 Billion ≈ $53.42 Million	0.217x	+93.60%
2008-12-31	₩278.85 Billion ≈ $188.97 Million	₩31.33 Billion ≈ $21.23 Million	0.112x	+17.33%
2007-12-31	₩269.57 Billion ≈ $182.68 Million	₩25.81 Billion ≈ $17.49 Million	0.096x	--

About Daewoong Pharma

KO:069620 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$944.29 Million

₩1.39 Trillion KRW

Market Cap Rank

#9314 Global

#251 in Korea

Share Price

₩121100.00

Change (1 day)

-1.94%

52-Week Range

₩118300.00 - ₩194000.00

All Time High

₩272265.92